Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4100)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2021 (publication date) through Jun 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shin K, Jung EK, Park SJ, Jeong S, Kim IH, Lee MA. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy. World J Gastrointest Oncol 2021; 13(8): 915-928 [PMID: 34457195 DOI: 10.4251/wjgo.v13.i8.915] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i8/915.htm |
| Number | Citing Articles |
| 1 |
Yu-qing Du, Xiu-mei Bai, Wei Yang, Zhong-yi Zhang, Song Wang, Wei Wu, Kun Yan, Min-hua Chen. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma. International Journal of Hyperthermia 2022; 39(1): 517 doi: 10.1080/02656736.2022.2048907
|
| 2 |
Xiu-Yun Lu, Xi Guo, Qi Zhang, Yi-Jie Qiu, Dan Zuo, Sheng Chen, Xiao-Fan Tian, Yu-Hong Zhou, Yi Dong, Wen-Ping Wang. Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound. Diagnostics 2022; 12(11): 2662 doi: 10.3390/diagnostics12112662
|
| 3 |
Jade Law, Harry Trieu, Guneet Kaleka, Joanna Turkiewicz, Samantha Palmer, Jennifer M. Lee, Kathryn T. Chen, James H. Tabibian. Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels. Cancers 2023; 15(6): 1723 doi: 10.3390/cancers15061723
|
| 4 |
Linjia Peng, Hao Chen. A novel nomogram and risk classification system based on inflammatory and immune indicators for predicting prognosis of pancreatic cancer patients with liver metastases. Cancer Medicine 2023; 12(18): 18622 doi: 10.1002/cam4.6471
|
| 5 |
Mitesh J. Borad, Li‐Yuan Bai, Donald Richards, Kabir Mody, Joleen Hubbard, Sun Young Rha, John Soong, Daniel McCormick, Emmett Tse, Daniel O'Brien, Ahmad Bayat, Daniel Ahn, S. Lindsey Davis, Joon Oh. Park, Do‐Youn Oh. Silmitasertib plus gemcitabine and cisplatin first‐line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study. Hepatology 2023; 77(3): 760 doi: 10.1002/hep.32804
|
| 6 |
Makoto Kadokura, Keisuke Tanaka, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Nobuyuki Enomoto. Significance of baseline and changes of tumor markers and neutrophil-to-lymphocyte ratio in predicting overall survival for patients with advanced pancreatic adenocarcinoma: A retrospective analysis. Journal of Cancer Research and Practice 2023; 10(2): 57 doi: 10.4103/ejcrp.eJCRP-D-22-00036
|
| 7 |
Kian Heshmat-Ghahdarijani, Vida Sarmadi, Afshin Heidari, Alireza Falahati Marvasti, Sina Neshat, Sina Raeisi. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1228076
|
| 8 |
Monika Kapszewicz, Ewa Małecka-Wojciesko. Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?. Journal of Clinical Medicine 2021; 10(22): 5463 doi: 10.3390/jcm10225463
|
| 9 |
Hillary G. Pratt, Kayla J. Steinberger, Nicole E. Mihalik, Sascha Ott, Thomas Whalley, Barbara Szomolay, Brian A. Boone, Timothy D. Eubank. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer. Cancers 2021; 14(1): 194 doi: 10.3390/cancers14010194
|